Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/01/24 05:15:04 on US and Canada Markets.
2024-04-01 05:15:04 ET Citigroup analyst issues SELL recommendation for SAVE on April 1, 2024 03:22AM ET. The previous analyst recommendation was Sell. SAVE was trading at $4.84 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...
2024-04-01 05:15:03 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for TT on April 1, 2024 03:37AM ET. The previous analyst recommendation was Underweight. TT was trading at $300.2 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-04-01 05:15:03 ET Wolfe Research analyst issues OUTPERFORM recommendation for CW on April 1, 2024 03:38AM ET. The previous analyst recommendation was Outperform. CW was trading at $255.94 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-04-01 05:15:03 ET Jefferies analyst issues BUY recommendation for AU on April 1, 2024 03:33AM ET. The previous analyst recommendation was Buy. AU was trading at $22.2 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...
2024-04-01 05:07:00 ET Home to the ninth-lowest beta in the S&P 500 index, snacking juggernaut The Hershey Company (NYSE: HSY) dispels the notion that "safe" stocks can't generate life-changing returns. While its 0.34 beta -- which measures the company's share price movement...
2024-04-01 05:05:00 ET A few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold a leading coronavirus vaccine -- and Pfizer sold a COVID treatment too -- and these products genera...
2024-04-01 05:05:00 ET A few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold a leading coronavirus vaccine -- and Pfizer sold a COVID treatment too -- and these products genera...
2024-04-01 05:00:03 ET Steve Fleishman from Wolfe Research issued a price target of $40.00 for EXC on 2024-04-01 03:38:00. The adjusted price target was set to $40.00. At the time of the announcement, EXC was trading at $37.57. The overall price target consensus is at $4...
2024-04-01 05:00:03 ET Myles Walton from Wolfe Research issued a price target of $300.00 for CW on 2024-04-01 03:38:00. The adjusted price target was set to $300.00. At the time of the announcement, CW was trading at $255.94. The overall price target consensus is at $234...
GUANGZHOU, China, April 01, 2024 (GLOBE NEWSWIRE) -- XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced its vehicle delivery results for March and the first quar...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.71%Change Percent:
Bone Biologics Corp Company Name:
BBLG Stock Symbol:
NASDAQ Market:
bonebiologics.com Website: